Nortech Systems Incorporated
NSYS
NASDAQ·Healthcare·Medical - Devices·Mkt cap $32.7M
$11.71
▲ +3.31%
P/E
31.65
Mkt Cap
$32.7M
52-Wk Range
$6.50–$18.01
52-Week Range
$6.50 - $18.01
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 25.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Specialized expertise in regulated industries (medical, aerospace, defense)
- Integrated design-to-manufacturing capabilities reducing time-to-market
- Multi-site operations in US, Mexico, and China enabling supply chain flexibility
- Strong engineering and testing capabilities for complex electromedical devices
Bear Case
1 risk
- Low volatility (beta 0.0).
Growth
No forward estimates available
Increasing outsourcing of manufacturing by OEMs seeking cost efficiency
Value
Valuation data unavailable
Momentum
Falling
-26.0% over 3m
Quality
Thin
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying NSYS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 12, 2026
Most recent quarter reported revenue of $33.5M (+9% YoY). Reported EPS of $0.11. Gross margin 17.0%.
Reported EPS · last 4Q
0 of 1 beats
Q3 26
—
Revenue trend · last 8Q
—
—
-21%
-9%
-3%
+6%
+13%
+9%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$31.4M
$28.6M
$26.9M
$30.7M
$30.5M
$30.3M
$30.3M
$33.5M
Margins · last 8Q
Gross
17.0%
Operating
1.9%
Profit
0.9%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How NSYS stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.